Everything you need to know about biotech VC

Perhaps you’re an entrepreneur baffled as to which VCs to pitch. Maybe you’re an investor curious about what your competitors are up to. Or maybe you need a deep dive into the whole bio-capitalist morass that consumes Cambridge and Silicon Valley alike.

It is with you in mind that we crafted “The STAT user’s guide to venture capital in biotech,” a 140-page report with profiles of more than 50 VC firms, interviews with key people, and granular information on just how money works in drug development.

You can buy it here, and you can look forward to future reports from STAT, including a breakdown of biopharma’s stakes in the coming election and an in-depth look at the science behind gene therapy. If you're a subscriber, you can enjoy a 20% discount. Email us at subscribers@statnews.com.